Anti-{alpha}iv{beta}i3 recombinant antibodies, functional fragments thereof, nucleic acid molecules encoding thereof and use of such antibodies
Rešení se týká protilátky s implantovaným zesíleným LM609 mající zesílenou selektivní vazebnou aktivitu .alfa..sub.V.n..beta..sub.3.n., nebo její funkcní fragment. Rovnež poskytuje molekuly nukleové kyseliny kódující protilátku s implantovaným zesíleným LM609. Dále poskytuje zpusoby inhibice funkce...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Czech English |
Published |
01.12.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rešení se týká protilátky s implantovaným zesíleným LM609 mající zesílenou selektivní vazebnou aktivitu .alfa..sub.V.n..beta..sub.3.n., nebo její funkcní fragment. Rovnež poskytuje molekuly nukleové kyseliny kódující protilátku s implantovaným zesíleným LM609. Dále poskytuje zpusoby inhibice funkce .alfa..sub.V.n..beta..sub.3 .n.kontaktem .alfa..sub.V.n..beta..sub.3 .n.s protilátkou s implantovaným zesíleným LM609.
The present invention relates to enhanced LM609 grafted antibodies exhibiting selective binding affinity to {alpha}iv{beta}i3, or a functional fragment thereof. The invention also provides nucleic acid molecules encoding the enhanced LM609 grafted antibodies. Additionally provided are methods of inhibiting a function of {alpha}iv{beta}i3 recombinant antibodies by contacting {alpha}iv{beta}i3 recombinant antibodies with an enhanced LM609 grafted antibody. |
---|---|
AbstractList | Rešení se týká protilátky s implantovaným zesíleným LM609 mající zesílenou selektivní vazebnou aktivitu .alfa..sub.V.n..beta..sub.3.n., nebo její funkcní fragment. Rovnež poskytuje molekuly nukleové kyseliny kódující protilátku s implantovaným zesíleným LM609. Dále poskytuje zpusoby inhibice funkce .alfa..sub.V.n..beta..sub.3 .n.kontaktem .alfa..sub.V.n..beta..sub.3 .n.s protilátkou s implantovaným zesíleným LM609.
The present invention relates to enhanced LM609 grafted antibodies exhibiting selective binding affinity to {alpha}iv{beta}i3, or a functional fragment thereof. The invention also provides nucleic acid molecules encoding the enhanced LM609 grafted antibodies. Additionally provided are methods of inhibiting a function of {alpha}iv{beta}i3 recombinant antibodies by contacting {alpha}iv{beta}i3 recombinant antibodies with an enhanced LM609 grafted antibody. |
Author | WU HERREN HUSE WILLIAM D |
Author_xml | – fullname: WU HERREN – fullname: HUSE WILLIAM D |
BookMark | eNqFjT0OwjAUgzvAwN8ZeAcACahEZ0AgDsDEgtJXp42UvlRNwoI4A1cmA0hsDJY9fLbH2UCcYJS9dhLM8qFs16inuT9KhOQ59WDXlkaUBEoypasM_IJ0FA7GibKke1W3kOApNOjh9IIksoVhUmwqap0FRwtPEE51qb9gWqwoelCKPnLz8zDNhlpZj9nHJ9n8dLwczkt07gbfKYYg3A7XfLVZF8V-m_8n3jlTULI |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | Anti-alfavbeta3 rekombinantní protilátky, její funkcní fragmenty, molekuly nukleové kyseliny je kódující a jejich použití |
ExternalDocumentID | CZ302177B6 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CZ302177B63 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:11:06 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Czech English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CZ302177B63 |
Notes | Application Number: CZ20010004655 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101201&DB=EPODOC&CC=CZ&NR=302177B6 |
ParticipantIDs | epo_espacenet_CZ302177B6 |
PublicationCentury | 2000 |
PublicationDate | 20101201 |
PublicationDateYYYYMMDD | 2010-12-01 |
PublicationDate_xml | – month: 12 year: 2010 text: 20101201 day: 01 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
RelatedCompanies | APPLIED MOLECULAR EVOLUTION, INC |
RelatedCompanies_xml | – name: APPLIED MOLECULAR EVOLUTION, INC |
Score | 2.7957792 |
Snippet | Rešení se týká protilátky s implantovaným zesíleným LM609 mající zesílenou selektivní vazebnou aktivitu .alfa..sub.V.n..beta..sub.3.n., nebo její funkcní... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | Anti-{alpha}iv{beta}i3 recombinant antibodies, functional fragments thereof, nucleic acid molecules encoding thereof and use of such antibodies |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101201&DB=EPODOC&locale=&CC=CZ&NR=302177B6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4gGvWmqMH3HgwnGrUv4NAYaSHEhEcMGsKFdB-VHmgJLXog_Ab_srMLRS4cmmzazbSdzXS-mc58C_DAESRQpguNBhVTMwNha75pIpATVZtbNUsXTOY72h279WG-DaxBDsZZL4ziCf1R5IhoUQztPVXf6-l_EstTtZXJIw3xVPzS7DteaR0dS7IqjI29utPodb2uW3Jdxx2WOu-OIbF3pW7vwb4E0ZJlv_FZlz0p022H0jyBgx7KitJTyLGkAEdutu9aAQ7b69_dOFxbXnIGv69RGmoL1Rq7DL8XFB9vGRpEBrQTqspZCB4hjWVZYJlIf7VK85Fg5n-pRjYiwZ6IgzKJJItxyIjPQk4mqx1yRUIkqaX0ZdlElMjJPBEEh8mcjbfucA73zUbfbWn4ZqONEkfuMFOBcQH5KI5EEYhfNXjVt2qBLQSuE6sZvCKY8Rxw64nbJr2E4i4pV7svXcOxvin6uIF8OpuLW3TdKb1TWv8DnBmj-w |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4gGvGmqMEnezCcaFT6gkNjpIWg8opBQ7iQ7nYrPVAILXog_Ab_srMLRS4cmmy6m-l2N9OZbzrzLcCdh04CZSWuUN_UFM3nhuJqGjpyvGx4ekUvcSbiHa220fjQXvt6PwWjpBZG8oT-SHJE1CiG-h7L7_X0P4jlyNzK6J4GeGvyVO9ZTmGNjgVZFWJjp2rVuh2nYxds27IHhfa7pQrf26wae7BvIiCUQOmzKmpSptsGpX4MB12UFcYnkGJRFjJ2cu5aFg5b69_d2FxrXnQKv89hHCgLWRq7DL4XFKe3DFQiAO2YynQWgldAJyItsEiEvVqF-Yg_c79kIRsRzh6f-EUSChbjgBGXBR4Zr07I5RERpJbCliUDUaJH5hEn2IzmbLT1hDPI12s9u6Hgmw03izi0B8kSqOeQDichzwFxy6pXdvWKb3CO-8Qqqmdypj76nv7gGRq9gNwuKZe7u_KQafRazWHzpf12BUelTQLINaTj2ZzfoBmP6a3cgT9tnabl |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Anti-%7Balpha%7Div%7Bbeta%7Di3+recombinant+antibodies%2C+functional+fragments+thereof%2C+nucleic+acid+molecules+encoding+thereof+and+use+of+such+antibodies&rft.inventor=WU+HERREN&rft.inventor=HUSE+WILLIAM+D&rft.date=2010-12-01&rft.externalDBID=B6&rft.externalDocID=CZ302177B6 |